Kit W. Tam, M.D. for UC Davis Health

Kit W. Tam, M.D.

Associate Professor

To see if Kit W. Tam is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).



Gastrointestinal Medicine


Internal Medicine

Locations and Contact

UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center
2279 45th Street
Sacramento, CA 95817

Get Directions

Phone: 916-734-5959

Additional Numbers

Clinic Phone


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Clinical Interests

Dr. Tam participates in clinical trials pertaining to oncology malignancies of gastrointestinal origin.

Research/Academic Interests

Dr. Tam's academic interests are developing education materials to the target patient population for Health And Life Organization (HALO) Sacramento clinics with the goal to enhance cancer screening and improve survival outcome among Asian Americans, Native Hawaiians and Pacific Islanders (AANHPIs).


Hematology and Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center

Undergraduate School

B.A., Public Health, Johns Hopkins University Bloomberg, Baltimore MD 2000

Medical School

M.D., University of Texas-Southwestern Medical School, Dallas TX 2008

Other School

M.H.S., Environmental Science, Johns Hopkins University Bloomberg School of Public Health, Baltimore MD 2002


Internal Medicine, University of Texas Southwestern Medical Center, Dallas TX 2009-2010


Internal Medicine, University of Texas Southwestern Medical Center, Dallas TX 2010-2012


Hematology Oncology, UC Davis Medical Center, Sacramento CA 2013-2016

1st place at the North Texas Chapter, Resident Poster Presentation at the American College of Physicians Annual Meeting, 2012

Chen H, Nguyen KNB, Huang H, Feng C, Zhao X, Daly ME, Rao S, Fragoso R, Valicenti R, Sekhon S, Navarro SM, Kim EJ, Cho M, Tam K, Farkas L, Halabi WJ, Monjazeb AM, Rong Y. Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer. Pract Radiat Oncol. 2020 Sep-Oct;10(5):e372-e377. doi:10.1016/j.prro.2019.12.007. Epub 2019 Dec 20. PMID:31866577.

Demisse R, Damle N, Kim E, Gong J, Fakih M, Eng C, Oesterich L, McKenny M, Ji J, Liu J, Louie R, Tam K, Gholami S, Halabi W, Monjazeb A, Dayyani F, Cho M. Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series. J Natl Compr Canc Netw. 2020 Jul;18(7):798-804. doi:10.6004/jnccn.2020.7558. PMID:32634770.

Judge SJ, Ji J, Liu J, Kaur M, Kim E, Gong J, Tam KW, Kirane AR, Gholami S, Canter RJ, Bold RJ, Gangi A, Fakih M, Cho M. The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report. Front Oncol. 2020 Apr 21;10:581. doi:10.3389/fonc.2020.00581. PMID:32373540.

Gong J, Robertson MD, Kim E, Fakih M, Schrock AB, Tam KW, Burugapalli B, Monjazeb AM, Hendifar AE, Hitchins M, Klempner SJ, Cho M. Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden. Clin Colorectal Cancer. 2019 Dec;18(4):307-309. doi:10.1016/j.clcc.2019.08.001. Epub 2019 Sep 4. PMID:31563511.

Tam KW, Zhang W, Soh J, Stastny V, Chen M, Sun H, Thu K, Rios JJ, Yang C, Marconett CN, Selamat SA, Laird-Offringa IA, Taguchi A, Hanash S, Shames D, Ma X, Zhang MQ, Lam WL, Gazdar A. CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer. J Thorac Oncol. 2013 Nov;8(11):1378-88. doi:10.1097/JTO.0b013e3182a46c0c. PMID:24077454.